Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-955176 Monotherapy and Combination in HIV-1
NCT01803074Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-955176 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Apr 2013; status: completed.
02
Drugs
BMS-955176
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01803074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01803074.